Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of the 2009 A/H1N1 influenza pandemic in patients with hematologic diseases: a prospective experience at an Italian center.
Girmenia C, Mercanti C, Federico V, Rea M, De Vellis A, Valle V, Micozzi A, Latagliata R, Breccia M, Morano SG, Brunetti GA, Sali M, Delogu G, Foà R, Alimena G, Gentile G. Girmenia C, et al. Among authors: valle v. Acta Haematol. 2011;126(1):1-7. doi: 10.1159/000323713. Epub 2011 Mar 11. Acta Haematol. 2011. PMID: 21411983
A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria.
Mannelli F, Bencini S, Peruzzi B, Cutini I, Sanna A, Benelli M, Magi A, Gianfaldoni G, Rotunno G, Carrai V, Gelli AM, Valle V, Santini V, Notaro R, Luzzatto L, Bosi A. Mannelli F, et al. Among authors: valle v. Cytometry B Clin Cytom. 2013 Mar;84(2):71-81. doi: 10.1002/cyto.b.21064. Epub 2012 Dec 26. Cytometry B Clin Cytom. 2013. PMID: 23281097 Free article.
Second-generation tyrosine kinase inhibitors before allogeneic stem cell transplantation in patients with chronic myeloid leukemia resistant to imatinib.
Breccia M, Palandri F, Iori AP, Colaci E, Latagliata R, Castagnetti F, Torelli GF, Usai S, Valle V, Martinelli G, Rosti G, Foà R, Baccarani M, Alimena G. Breccia M, et al. Among authors: valle v. Leuk Res. 2010 Feb;34(2):143-7. doi: 10.1016/j.leukres.2009.04.036. Epub 2009 May 29. Leuk Res. 2010. PMID: 19481800
The immune reconstitution after an allogeneic stem cell transplant correlates with the risk of graft-versus-host disease and cytomegalovirus infection.
Torelli GF, Lucarelli B, Iori AP, De Propris MS, Capobianchi A, Barberi W, Valle V, Iannella E, Natalino F, Mercanti C, Perrone S, Gentile G, Guarini A, Foà R. Torelli GF, et al. Among authors: valle v. Leuk Res. 2011 Aug;35(8):1124-6. doi: 10.1016/j.leukres.2011.03.009. Epub 2011 Apr 2. Leuk Res. 2011. PMID: 21459444
The limit for chronic myeloid leukemia relapse after allogeneic hematopoietic stem cell transplant moves ever forward: when can you safely talk about healing?
Iori AP, Breccia M, Girmenia C, Perrone S, Valle V, Natalino F, Barberi W, Scalzulli E, Torelli GF, Puzzolo MC, Foà R. Iori AP, et al. Among authors: valle v. Leuk Lymphoma. 2013 Mar;54(3):669-70. doi: 10.3109/10428194.2012.715348. Epub 2012 Oct 4. Leuk Lymphoma. 2013. PMID: 23036078 No abstract available.
240 results